Perceived barriers to NGS-based molecular profiling in metastatic breast cancer.
Year: 2025
Type: conference-abstract
Source: JCO Oncology Practice
Institutions: Health Advances (United States), AstraZeneca (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4414913381
Cites:
Cited by:
Related to:
